Enhanced cellular uptake of folic acidconjugated PLGAPEG nanoparticles loaded with vincristine sulfate in human breast cancer

Drug Development and Industrial Pharmacy

Volumn 37, Issue 11, 2011, Pages 1339-1346

  Chen, Jianian ^a   Li, Shaoshun ^a   Shen, Qi ^a   He, Huijuan ^a   Zhang, Yi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cellular uptake; Conjugation; Folic acid; Nanoparticle; PLGAPEG; Vincristine sulfate

Indexed keywords

COUMARIN; FOLATE RECEPTOR; FOLIC ACID; MACROGOL; NANOPARTICLE; POLYGLACTIN; VINCRISTINE SULFATE; WATER OIL CREAM;

ARTICLE; BREAST CANCER; CANCER CELL DESTRUCTION; CELL STRAIN MCF 7; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG UPTAKE; ENDOCYTOSIS; EVAPORATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; MORPHOLOGY; NANOENCAPSULATION; PARTICLE SIZE; POLYMERIZATION; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SURFACE PROPERTY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL SURVIVAL; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FOLIC ACID; HUMANS; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 80053967517     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.575162     Document Type: Article

References (38)

1. van Vlerken LE, Vyas TK, Amiji MM. (2007). Poly(ethylene glycol)- modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res, 24:1405-1414. (Pubitemid 46988224)
2. Wang Z, Chui WK, Ho PC. (2009). Design of a multifunctional PLGA nanoparticulate drug delivery system: Evaluation of its physicochemical properties and anticancer activity to malignant cancer cells. Pharm Res, 26:1162-1171.
3. Wang M, Thanou M. (2010). Targeting nanoparticles to cancer. Pharmacol Res, 62:90-99.
4. Hilgenbrink AR, Low PS. (2005). Folate receptor-mediated drug targeting: From therapeutics to diagnostics. J Pharm Sci, 94:2135-2146. (Pubitemid 41665275)
5. Kim S, Lee J. (2011). Folate-targeted drug-delivery systems prepared by nano-comminution. Drug Dev Ind Pharm, 37:131-138.
6. Saul JM, Annapragada AV, Bellamkonda RV. (2006). A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J Control Release, 114:277-287. (Pubitemid 44310813)
7. Zhao D, Zhao X, Zu Y, Li J, Zhang Y, Jiang R, Zhang Z. (2010). Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomed, 5:669-677.
8. Stella B, Arpicco S, Peracchia MT, Desmaële D, Hoebeke J, Renoir M, D'Angelo J, Cattel L, Couvreur P. (2000). Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci, 89:1452-1464.
9. Cil T, Altintas A, Tamam Y, Battaloglu E, Isikdogan A. (2009). Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: A case report (vincristine-induced severe polyneuropathy). J Pediatr Hematol Oncol, 31:787-789.
10. Moore A, Pinkerton R. (2009). Vincristine: Can its therapeutic index be enhanced?. Pediatr Blood Cancer, 53:1180-1187.
11. Rodriguez MA, Pytlik R, Kozak T, Chhanabhai M, Gascoyne R, Lu B, Deitcher SR, Winter JN; Marqibo Investigators. (2009). Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: Report of the pivotal phase 2 study. Cancer, 115:3475-3482.
12. Ravi Kumar MN, Bakowsky U, Lehr CM. (2004). Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials, 25:1771-1777. (Pubitemid 38102253)
13. Lü JM, Wang X, Marin-Muller C, Wang H, Lin PH, Yao Q, Chen C. (2009). Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn, 9:325-341.
14. Diao YY, Han M, Ding PT, Chen DW, Gao JQ. (2010). DOX-loaded PEG-PLGA and Pluronic copolymer composite micelles enhances cytotoxicity and the intracellular accumulation of drug in DOXresistant tumor cells. Pharmazie, 65:356-358.
15. Kamaly N, Kalber T, Thanou M, Bell JD, Miller AD. (2009). Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. Bioconjugate Chem, 20:648-655.
16. Shi G, Guo W, Stephenson SM, Lee RJ. (2002). Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J Control Release, 80:309-319. (Pubitemid 34273768)
17. Wang H, Zhao P, Liang X, Gong X, Song T, Niu R, Chang J. (2010). Folate-PEG coated cationic modified chitosan-cholesterol liposomes for tumor-targeted drug delivery. Biomaterials, 31:4129-4138.
18. Hattori Y, Maitani Y. (2004). Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer. J Control Release, 97:173-183. (Pubitemid 38624519)
19. Pan J, Feng SS. (2008). Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. Biomaterials, 29:2663-2672.
20. Lee ES, Na K, Bae YH. (2005). Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release, 103:405-418. (Pubitemid 40342538)
21. Zhao H, Yung LY. (2008). Selectivity of folate conjugated polymer micelles against different tumor cells. Int J Pharm, 349:256-268. (Pubitemid 350299702)
22. Song XR, Cai Z, Zheng Y, He G, Cui FY, Gong DQ, Hou SX, Xiong SJ, Lei XJ, Wei YQ. (2009). Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. Eur J Pharm Sci, 37:300-305.
23. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Livaniou E, Evangelatos G, Ithakissios DS. (2003). Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int J Pharm, 259:115-127. (Pubitemid 36638559)
24. Beletsi A, Leontiadis L, Klepetsanis P, Ithakissios DS, Avgoustakis K. (1999). Effect of preparative variables on the properties of poly(dllactide- co-glycolide)-methoxypoly(ethyleneglycol) copolymers related to their application in controlled drug delivery. Int J Pharm, 182:187-197. (Pubitemid 29248847)
25. Esmaeili F, Ghahremani MH, Ostad SN, Atyabi F, Seyedabadi M, Malekshahi MR, Amini M, Dinarvand R. (2008). Folate-receptortargeted delivery of docetaxel nanoparticles prepared by PLGAPEG-folate conjugate. J Drug Target, 16:415-423. (Pubitemid 351935739)
26. Wang L, Wang S, Bei Jz. (2004). Synthesis and characterization of macroinitiator-amino terminated PEG and poly(γ-benzyl-L-glutamate)- PEO-poly(γ-benzyl-L-glutamate) triblock copolymer. Polym Advan Technol, 15: 617-621. (Pubitemid 39500190)
27. Yoo HS, Park TG. (2004). Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release, 96:273-283. (Pubitemid 38481509)
28. Cohen-Sela E, Teitlboim S, Chorny M, Koroukhov N, Danenberg HD, Gao J, Golomb G. (2009). Single and double emulsion manufacturing techniques of an amphiphilic drug in PLGA nanoparticles: Formulations of mithramycin and bioactivity. J Pharm Sci, 98:1452-1462.
29. Meng FT, Ma GH, Qiu W, Su ZG. (2003). W/O/W double emulsion technique using ethyl acetate as organic solvent: Effects of its diffusion rate on the characteristics of microparticles. J Control Release, 91:407-416. (Pubitemid 36976770)
30. Sheshala R, Peh KK, Darwis Y. (2009). Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery. Drug Dev Ind Pharm, 35:1364-1374.
31. Cavalli R, Donalisio M, Civra A, Ferruti P, Ranucci E, Trotta F, Lembo D. (2009). Enhanced antiviral activity of Acyclovir loaded into β-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles. J Control Release, 137:116-122.
32. Hu K, Li J, Shen Y, Lu W, Gao X, Zhang Q, Jiang X. (2009). Lactoferrinconjugated PEG-PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations. J Control Release, 134:55-61.
33. Davda J, Labhasetwar V. (2002). Characterization of nanoparticle uptake by endothelial cells. Int J Pharm, 233:51-59. (Pubitemid 34230418)
34. Win KY, Feng SS. (2005). Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26:2713-2722.
35. Stella B, Marsaud V, Arpicco S, Géraud G, Cattel L, Couvreur P, Renoir JM. (2007). Biological characterization of folic acidconjugated poly(H2NPEGCA-co-HDCA) nanoparticles in cellular models. J Drug Target, 15:146-153. (Pubitemid 46957701)
36. Wu L, Tang C, Yin C. (2010). Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Drug Dev Ind Pharm, 36:439-448.
37. Pinhassi RI, Assaraf YG, Farber S, Stark M, Ickowicz D, Drori S, Domb AJ, Livney YD. (2010). Arabinogalactan-folic acid-drug conjugate for targeted delivery and target-activated release of anticancer drugs to folate receptor-overexpressing cells. Biomacromolecules, 11:294-303.
38. Yang SJ, Lin FH, Tsai KC, Wei MF, Tsai HM, Wong JM, Shieh MJ. (2010). Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells.. Bioconjugate Chem, 21:679-689.